Here's Why Thermo Fisher Scientific Jumped 45.1% in 2019
Shares of Thermo Fisher Scientific (NYSE: TMO) lept over 45% last year, according to data provided by S&P Global Market Intelligence. The scientific-research products monopoly didn't do anything impressive, but its massive market position means it didn't have to. The growth stock easily bested the roughly 29% gain of the S&P 500 in 2019.
In the first nine months of 2019, the business reported revenue of $18.7 billion, marking a 4.8% increase from the year-ago period. Operating income barely budged, although that was entirely due to a $442 million restructuring charge. Investors are nonetheless content with the company's moves to position itself for future growth.
Image source: Getty Images.
Source Fool.com
